Hongkong Kangdisen Medical Co., Limited

Serve People's Health

Home
Products
About Us
Factory Tour
Quality Control
Contact Us
Request A Quote
Home ProductsNicotinamide Riboside NR

Apo-Tamox 10540-29-1 Nicotinamide Riboside NR Supplement Nolvadex Genox

Certification
Good quality Testosterone Anabolic Steroid for sales
Good quality Testosterone Anabolic Steroid for sales
You have nice products and good service. I like yoiur STRONGTROPIN HGH. It is very good .

—— Lisa Brown

Very fast shipping. My clients used your HGH. Its quality is very good. Is it original ?

—— John Kenemy

I ordered your HGH two weeks ago. My friend used it and like it now. Thanks for your patience. we will continue to use your products.

—— Kelly Smith

Thanks. I got the real HGH. In the past few years, I got many fakes. Nothing in the vials, only white powder. You will be my best supplier. My God.

—— Robert Lemy

Are you the only STRONGTROPIN HGH supplier ? It is the best HGH I got. I will recommend it to some of my friends here. Thank you so much.

—— Edwin Kendall

I'm Online Chat Now

Apo-Tamox 10540-29-1 Nicotinamide Riboside NR Supplement Nolvadex Genox

China Apo-Tamox 10540-29-1 Nicotinamide Riboside NR Supplement Nolvadex Genox supplier

Large Image :  Apo-Tamox 10540-29-1 Nicotinamide Riboside NR Supplement Nolvadex Genox

Product Details:

Place of Origin: China
Brand Name: KANGDISEN
Certification: GMP
Model Number: white powder

Payment & Shipping Terms:

Minimum Order Quantity: negotiatable
Price: Negotiatalbe
Packaging Details: botttles
Delivery Time: 3 days
Payment Terms: MoneyGram, Western Union, T/T, Bitcoin
Supply Ability: 100,000 kg each month
Contact Now
Detailed Product Description
IUPHAR/BPS: 1016 Appearance: White Powder
DrugBank: DB00675 ChemSpider: 2015313
Synonyms: Nolvadex, Genox, Tamifen CAS: 10540-29-1
High Light:

nicotinamide riboside supplement

,

nicotinamide riboside synthesis

Apo-Tamox 10540-29-1 Nicotinamide Riboside NR Supplement Nolvadex Genox

 

 

 

Tamoxifen, the generic name of Nolvadex, is the oldest and most-prescribed SERM. Tamoxifen is approved by the U.S. Food and Drug Administration (FDA) to treat:

 

  • women and men diagnosed with hormone-receptor-positive, early-stage breast cancer after surgery (or possibly chemotherapy and radiation) to reduce the risk of the cancer coming back (recurring)

  • women and men diagnosed with advanced-stage or metastatic hormone-receptor-positive disease

 

Tamoxifen also is used to:

 

  • reduce breast cancer risk in women who haven't been diagnosed but are at higher-than-average risk for disease

 

Tamoxifen won't work on hormone-receptor-negative breast cancer.

Tamoxifen is a pill taken once a day. Most doctors recommend taking tamoxifen at the same time each day.

 

You should not take tamoxifen if you are breastfeeding, pregnant, trying to get pregnant, or if there is any chance that you could be pregnant. Tamoxifen may cause damage to developing embryos. You should use an effective non-hormonal type of birth control -- such as condoms, a diaphragm along with spermicide, or a non-hormonal I.U.D. – while you are taking tamoxifen and for 2 months afterward. Ask your doctor which type of non-hormonal birth control would be best for you.

 

 

Benefits of tamoxifen

 

Since its approval in 1998, tamoxifen has been used to treat millions of women and men diagnosed with hormone-receptor-positive breast cancer. While an aromatase inhibitor is the first hormonal therapy medicine choice for postmenopausal women, tamoxifen is the first choice for premenopausal women and is still a good choice for postmenopausal women who can't take an aromatase inhibitor.

Tamoxifen can:

 

  • reduce the risk of breast cancer coming back by 40% to 50% in postmenopausal women and by 30% to 50% in premenopausal women

  • reduce the risk of a new cancer developing in the other breast by about 50%

  • shrink large, hormone-receptor-positive breast cancers before surgery

  • slow or stop the growth or advanced (metastatic) hormone-receptor-positive breast cancer in both pre- and postmenopausal women

  • lower breast cancer risk in women who have a higher-than-average risk of disease but have not been diagnosed

 

Tamoxifen offers other health benefits that aren't related to treating cancer. Because it's a SERM, it selectively either blocks or activates estrogen's action on specific cells. While tamoxifen blocks estrogen's action on breast cells, it activates estrogen's action in bone and liver cells. So tamoxifen can:

 

  • help stop bone loss after menopause

  • lower cholesterol levels

 

Some people may not get the full benefit of tamoxifen

 

The body uses an enzyme called CYP2D6 to convert tamoxifen into its active form. Two things can interfere with the body’s ability to make this happen: a flaw in the CYP2D6 enzyme and certain medications that block the effectiveness of this enzyme.

 

  • Abnormal CYP2D6 enzyme: About 10% of people have a CYP2D6 enzyme that doesn’t function as well as it should. Having an abnormal CYP2D6 enzyme might keep a person from getting the full benefit of tamoxifen. You may want to ask your doctor about being tested for this enzyme abnormality if you are considering taking tamoxifen. Still,CYP2D6 testing is controversial because several large studies found that an abnormal CYP2D6 enzyme didn’t affect tamoxifen’s effectiveness. Together, you and your doctor can decide if CYP2D6 testing makes sense for your unique situation.

  •  

  • Medications that can interfere with CYP2D6: There are medications that can block the activity of CYP2D6 to varying degrees (usually stated as “strong” or “moderate” inhibitors of CYP2D6). These medications include some of the antidepressants known as serotonin-specific reuptake inhibitors (SSRIs) and serotonin-norepinephrine reuptake inhibitors (SNRIs). There are also other types of commonly prescribed medications, such as Cardioquin (chemical name: quinidine), Benadryl (chemical name: diphenhydramine), and Tagamet (chemical name: cimetidine), that can block CYP2D6. Blocking the activity of CYP2D6 can interfere with the activation of tamoxifen — reducing its effectiveness as an anti-cancer treatment. Most doctors recommend that you avoid taking strong and moderate inhibitors of CYP2D6 while you’re on tamoxifen.



  • If you have already finished tamoxifen and you were taking other medications at the same time, make an appointment to talk with your doctor about whether any of your other medications may have interfered with CYP2D6 and the potential benefit you received from tamoxifen. Your doctor may recommend no additional therapy or extended hormonal therapy (with tamoxifen or an aromatase inhibitor) depending on your risk of recurrence, your overall medical condition, and your preferences.



  • If you were taking tamoxifen because you are at high risk but have never been diagnosed, and you were also taking a CYP2D6 inhibitor, your doctor may now recommend additional anti-estrogen therapy with tamoxifen or Evista (chemical name: raloxifene), depending on your menopausal status. Talk to your doctor about what’s best for your situation.



  • If you had progression of breast cancer while on both tamoxifen and a strong or moderate CYP2D6 inhibitor, you can’t assume that tamoxifen failed to work. Rather, it’s possible that tamoxifen never had a fair chance at getting the cancer under control because its action was blocked by the other medicine. Moving forward, tamoxifen, without a CYP2D6 inhibitor, may still provide significant benefit.

  •  

For those taking raloxifene (brand name: Evista)

 

The CYP2D6 enzyme is not needed to activate raloxifene (brand name: Evista, a sister medicine to tamoxifen, used to reduce the risk of developing hormone-receptor-positive breast cancer and treat osteoporosis in postmenopausal women).

 

 

Medicines to avoid while taking tamoxifen

 

In the list below, the medications under the headings “Strong Inhibitors” and “Moderate Inhibitors” can inhibit CYP2D6 and interfere with the effectiveness of tamoxifen. The medications under the heading “Not Inhibitors” do not block the CYP2D6 enzyme and will not interfere with tamoxifen treatment.

 

This list is incomplete and subject to change over time. Use it as a starting place and ask your doctor if any medications you are taking or that are recommended to you are compatible with tamoxifen.

 

Strong Inhibitors

Generic Names

Brand Names

Bupropion

Wellbutrin

Fluoxetine

Prozac

Paroxetine

Paxil

Quinidine

Cardioquin

Moderate Inhibitors

Generic Names

Brand Names

Duloxetine

Cymbalta

Sertraline

Zoloft

Diphenhydramine

Benadryl

Thioridazine

Mellaril

Amiodarone

Cordarone

Trazodone

Desyrel

Cimetidine

Tagamet

SSRIs and SNRIs That Are Not Inhibitors

Generic Names

Brand Names

Venlavaxine

Effexor

Citalopram

Celexa

Escitalopram

Lexapro

Contact Details
Hongkong Kangdisen Medical Co., Limited

Contact Person: Mr. YANG

Tel: 86-159-8986-9841

Fax: 86-159-8986-9841

Send your inquiry directly to us (0 / 3000)